October 31, 2006
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that Ben Bonifant, Vice President of its Business Development Practice, will be presenting a workshop as part of the
Mr. Bonifant's workshop, "11 Missteps in Valuation and How to Avoid Them," will discuss some of the more frequently encountered errors in valuation models. The audience will then participate in an interactive discussion of how decision makers can increase the likelihood that the models they rely on reflect the "real world" of pharmaceutical commercialization. The workshop will be conducted on Friday, November 3, from to Mr. Bonifant presented a similar workshop at the Advanced Business Development Course held in conjunction with
The list of potential missteps related to valuations is long. Mr. Bonifant's "top 11," which he will cover during this workshop session, are:
1. Prevalent means relevant.
2. Any available data are good.
3. It's all about us.
4. It's all about efficacy.
5. All patients are compliant.
6. The product will sell itself.
7. A ready market awaits us.
8. All patients will have access.
9. Assumptions about average wholesale price are valid.
10. The price will never increase.
11. Post-marketing trials are free.
For more information, please visit http://www.exectraining.bio.org/opencms/training/advanced/home.jsp or http://www.ebdgroup.com/busdevcourse.
About the Business Development Practice at
The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech business development who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out-licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives chart new strategies in corporate development.
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's "top 20" pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales. From its locations in